Shotgun proteomics of human bile in hilar cholangiocarcinoma

Proteomics

Volumn 11, Issue 10, 2011, Pages 2134-2138

  Farid, Shahid G ^a   Craven, Rachel A ^a   Peng, Jianhe ^a   Bonney, Glenn K ^a   Perkins, David N ^a   Selby, Peter J ^a   Rajendra Prasad, K ^a   Banks, Rosamonde E ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Bile; Biomedicine; Cholangiocarcinoma; Shotgun proteomics

Indexed keywords

BIOLOGICAL MARKER; GENE PRODUCT; PROTEOME;

ARTICLE; BILE; BILE DUCT CARCINOMA; HUMAN; LIVER HILUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS;

BILE; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHROMATOGRAPHY, LIQUID; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; HUMANS; PEPTIDE MAPPING; PROTEINS; PROTEOME; TANDEM MASS SPECTROMETRY;

EID: 79955763228     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000653     Document Type: Article

References (16)

1. Khan, S. A., Thomas, H. C., Davidson, B. R., Taylor-Robinson, S. D., Cholangiocarcinoma. Lancet 2005, 366, 1303-1314.
2. Hidalgo, E., Asthana, S., Nishio, H., Wyatt, J. et al., Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur. J. Surg. Oncol. 2008, 34, 787-794.
3. Ito, F., Cho, C. S., Rikkers, L. F., Weber, S. M., Hilar cholangiocarcinoma: current management. Ann. Surg. 2009, 250, 210-218.
4. Bonney, G. K., Craven, R. A., Prasad, R., Melcher, A. F. et al., Circulating markers of biliary malignancy: opportunities in proteomics? Lancet Oncol. 2008, 9, 149-158.
5. Farina, A., Dumonceau, J. M., Lescuyer, P., Proteomic analysis of human bile and potential applications for cancer diagnosis. Expert Rev. Proteomics 2009, 6, 285-301.
6. Kristiansen, T. Z., Bunkenborg, J., Gronborg, M., Molina, H. et al., A proteomic analysis of human bile. Mol. Cell. Proteomics 2004, 3, 715-728.
7. Zhou, H., Chen, B., Li, R. X., Sheng, Q. H. et al., Large-scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach. Rapid Commun. Mass Spectrom. 2005, 19, 3569-3578.
8. Guerrier, L., Claverol, S., Finzi, L., Paye, F. et al., Contribution of solid-phase hexapeptide ligand libraries to the repertoire of human bile proteins. J. Chromatogr. A 2007, 1176, 192-205.
9. Farina, A., Dumonceau, J. M., Frossard, J. L., Hadengue, A. et al., Proteomic analysis of human bile from malignant biliary stenosis induced by pancreatic cancer. J. Proteome Res. 2009, 8, 159-169.
10. Aggelis, V., Craven, R. A., Peng, J., Harnden, P. et al., Proteomic identification of differentially expressed plasma membrane proteins in renal cell carcinoma by stable isotope labeling of a von Hippel-Lindau transfectant cell line model. Proteomics 2009, 9. 2118-2130.
11. Schenk, S., Schoenhals, G. J., de Souza, G., Mann, M., A high confidence manually validated human blood plasma protein reference set. BMC Med. Genomics 2008, 15, 1-41.
12. Park, S. Y., Roh, S. J., Kim, Y. N., Kim, S. Z. et al., Expression of MUC1, MUC2, MUC5AC and MUC6 in cholangiocarcinoma: prognostic impact. Oncol. Rep. 2009, 22, 649-657.
13. Srisomsap, C., Sawangareetrakul, P., Subhasitanont, P., Chokchaichamnankit, D. et al., Proteomic studies of cholangiocarcinoma and hepatocellular carcinoma cell secretomes. J. Biomed. Biotechnol. 2010, 2010, 437143.
14. Korita, P. V., Wakai, T., Ajioka, Y., Inoue, M. et al., Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma. Anticancer Res. 2010, 30, 2279-2285.
15. Dos Santos, A., Court, M., Thiers, V., Sar, S. et al., Identification of cellular targets in human intrahepatic cholangiocarcinoma using laser microdissection and accurate mass and time tag proteomics. Mol. Cell. Proteomics 2010, 9, 1991-2004.
16. Koopmann, J., Thuluvath, P. J., Zahurak, M. L., Kristiansen, T. Z. et al., Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 2004, 101, 1609-1615.